Clinical trial
Imaging to Re-evaluate Elacestrant Clinical Application
NCT07753954 is registered in ClinicalTrials.gov with Jules Bordet Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Imaging to Re-evaluate Elacestrant Clinical Application
- Lead sponsor
- Jules Bordet Institute
- Phase
- Phase 2
- Overall status
- Not yet recruiting
- Start date
- September 13, 2026
- Completion date
- August 19, 2031
- Enrollment
- 160 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
er+ / her2- advanced breast cancer